Gastroenterology

Gastroenterology

Volume 117, Issue 2, August 1999, Pages 414-419
Gastroenterology

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels

https://doi.org/10.1053/gast.1999.0029900414Get rights and content

Abstract

Background & Aims: Long-term primary antibiotic prophylaxis of spontaneous bacterial peritonitis has been suggested to be useful in cirrhotic patients with low ascitic fluid protein levels. However, it is unlikely that all such patients need prophylactic treatment. The aim of this study was to identify the group of cirrhotic patients with low ascitic fluid protein levels at high risk of developing a first episode of spontaneous bacterial peritonitis during outpatient follow-up. Methods: One hundred nine cirrhotic patients with low ascitic fluid protein levels and without previous episodes of spontaneous bacterial peritonitis were followed up in an outpatient clinic. Results: Twenty-eight patients developed a first spontaneous bacterial peritonitis episode. In the multivariate analysis, serum bilirubin level (>3.2 mg /dL) and platelet count (<98.000/mm3) independently correlated with the risk of developing the first spontaneous bacterial peritonitis (P < 0.01 and P < 0.05, respectively). According to the median relative risk coefficient, a low-risk group (relative risk <1.09) and a high-risk group (relative risk >1.09) were established. The probability of developing a first spontaneous bacterial peritonitis episode at 1-year follow-up was significantly higher in the high risk-group (low-risk group, 23.6%; high-risk group, 55%; P < 0.01) as a consequence of a higher probability of the first community-acquired episode (13.7% vs. 47.6%, respectively, P < 0.01). One-year probability of survival was significantly lower in the high-risk group (low-risk group, 57.6%; high-risk group, 38%, P < 0.05). Conclusions: Cirrhotic patients with low ascitic fluid protein levels (≤1 g /dL) and high bilirubin level and/or low platelet count are at high risk of developing a first episode of spontaneous bacterial peritonitis during long-term follow-up.

Section snippets

Patients and methods

One hundred nine cirrhotic patients with low ascitic fluid total protein levels (≤1g/dL) and without a previous episode of SBP, admitted to the Hospital del Mar or the Hospital de la Santa Creu i Sant Pau in Barcelona between January 1994 and December 1995, were included in the study after discharge from the hospital. Exclusion criteria were severe hepatic insufficiency (serum bilirubin concentration >15 mg/dL), advanced renal dysfunction (serum creatinine concentration >3 mg/dL), or evidence

Results

One hundred nine patients with low ascitic fluid total protein levels (≤1 g/dL) and without a previous episode of SBP were included in the study. Sixty patients were from the Hospital del Mar and 49 from the Hospital Sant Pau. During a mean follow-up of 45 weeks (range, 4-143 weeks), 28 patients developed an episode of SBP. Nine ascitic fluid infections were acquired during a hospitalization. Clinical and analytical characteristics of patients are shown in Table 1.

. Table 1. Clinical and

Discussion

Previous studies have shown that the incidence of SBP is higher in patients with ascitic fluid total protein levels ≤1 g/dL than in patients with a protein concentration in ascitic fluid of >1 g/dL, not only during the hospitalization24, 25 but also during long-term follow-up.15, 17 Between 15% and 30% of cirrhotic patients with low ascitic fluid total protein levels are infected at admission or develop an episode of SBP during hospitalization.24, 25 In addition, the cumulative probability of

References (30)

  • J. Such et al.

    Low C3 in ascitic fluid predisposes to spontaneous bacterial peritonitis

    J Hepatol

    (1988)
  • C. Guarner et al.

    Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management

    Gastroenterologist

    (1995)
  • P. Gines et al.

    Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

    Hepatology

    (1990)
  • N. Singh et al.

    Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

    Ann Intern Med

    (1995)
  • J.D. Grange et al.

    Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind, randomized trial

    J Hepatol

    (1998)
  • Cited by (159)

    • Use of prokinetic agents or antibiotics is associated with the occurrence of spontaneous bacterial peritonitis in cirrhotic patients

      2018, Journal of the Chinese Medical Association
      Citation Excerpt :

      Since the occurrence of SBP markedly worsens the prognosis in cirrhotic patients, numerous researches have studied the risk factors associated with the occurrence of SBP. In addition to the well established risk factors such as advanced liver dysfunction,6,7 gastrointestinal (GI) bleeding and low ascitic protein,8,9 medications may also affect the chances of developing SBP. The use of acid suppressive therapy including proton pump inhibitors (PPIs) or H2 receptor antagonist (H2RA) has been found to have a potential association with the occurrence of SBP.10–12

    • Sepsis in alcohol-related liver disease

      2017, Journal of Hepatology
    View all citing articles on Scopus
    View full text